Back to Biologics
About
Christopher Lane co-founded BioOrtho Therapeutics, which raised $120M Series C to advance its allograft-based cartilage restoration platform. He previously led biologics strategy at Stryker.
Articles by Christopher Lane
No published articles yet.
Comments by Christopher Lane
No comments yet.